Evidence map›Paper›PMID 42243173›Full record

ArticleScientific reports2026

Caucasian and Egyptian chitosan/propolis nanocomposites inhibit deformed wing virus in Apis mellifera L. cell lines.

Heba Seyam, Sameh H Ismail, Heba M Hamama

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Heba SeyamHoney Bee Research Department, Plant Protection Research Institute, Agricultural Research Center, Giza, Egypt. heba.seyam@yahoo.com.ORCID 0009-0006-4866-6380
Sameh H IsmailFaculty of Postgraduate Studies for Nanotechnology, Cairo University, El-Sheikh Zayed Branch Campus, PO Box 12588, Giza, Egypt.
Heba M HamamaFaculty of Postgraduate Studies for Nanotechnology, Cairo University, El-Sheikh Zayed Branch Campus, PO Box 12588, Giza, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Honey bees face threats from a variety of pathogens and viruses, the most dangerous of which is the deformed wing virus [DWV]. Using natural materials as treatments or nutritional supplements for bees is the ideal solution, especially when transformed into nanoparticles. Propolis is a resinous product collected from honeybee colonies and is known for its wide-ranging therapeutic properties. The nanocomposite of the chitosan/ propolis alcoholic extracts were prepared and characterized for determining their chemical and physical properties. Cytotoxicity assay and antiviral activity of the prepared composites were also determined using cell culture from the head of adult honey bees in a dose-response assay. A quantitative real time-polymerase chain reaction [RT-qPCR] was done to measure their effects on the deformed wing virus load. The characterization results showed that the Caucasian propolis-chitosan nanocomposite have a higher phenols and flavonoid content and surface area compared to the Egyptian propolis. The Caucasian propolis showed higher toxicity to the cultured cells than the Egyptian propolis. The Chitosan-Caucasian propolis nanocomposites caused a more reduction in the deformed wing viral load of the honey bee cell line than the Egyptian one compared to the raw propolis. It is recommended to use the chitosan-Caucasian propolis nanocomposite as therapeutic and nutritional supplements for decreasing the deformed wing viral load in the honey bees a process that may help in increasing their performance and bee-product production.

Indexed as

Antiviral AgentsChitosanNanocompositesPropolisRNA VirusesAnimalsBeesCell LineAntiviral AgentsChitosanPropolisCell linesChitosanDeformed wing virusHoney beeNanoparticlesPropolis

Identifiers

PMID42243173
PMCPMC13237102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.